Literature DB >> 8662028

Effects of gender, age, and heart rate on QT intervals in children.

W Pearl1.   

Abstract

The objective of this study was to determine if gender, age, and heart rate affect corrected QT intervals in children. Electrocardiograms were obtained from 781 healthy children 10-18 years of age. Corrected QT intervals were significantly (p < 0.0005) greater for girls than for boys in the entire population and for each age group over 14 years. The corrected QT interval varied inversely with age and directly with heart rate. Hence gender, age, and heart rate should be considered when diagnosing long QT syndrome.

Entities:  

Mesh:

Year:  1996        PMID: 8662028     DOI: 10.1007/BF02505201

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  3 in total

Review 1.  Rate-corrected QT interval: techniques and limitations.

Authors:  C Funck-Brentano; P Jaillon
Journal:  Am J Cardiol       Date:  1993-08-26       Impact factor: 2.778

Review 2.  Diagnostic criteria for the long QT syndrome. An update.

Authors:  P J Schwartz; A J Moss; G M Vincent; R S Crampton
Journal:  Circulation       Date:  1993-08       Impact factor: 29.690

3.  Electrocardiographic quantitation of ventricular repolarization.

Authors:  M Merri; J Benhorin; M Alberti; E Locati; A J Moss
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

  3 in total
  14 in total

Review 1.  The normal ECG in childhood and adolescence.

Authors:  David F Dickinson
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

2.  QTc interval prolongation in children with Ulrich-Turner syndrome.

Authors:  Robert Dalla Pozza; Susanne Bechtold; Stefan Kääb; Matthias Buckl; Simon Urschel; Heinrich Netz; Hans-Peter Schwarz
Journal:  Eur J Pediatr       Date:  2006-07-12       Impact factor: 3.183

3.  Clinical determinants of electrocardiographic and spatial vectorcardiographic descriptors of ventricular repolarization in healthy children.

Authors:  Polychronis Dilaveris; Dimitrios Roussos; Georgios Giannopoulos; Stylianos Katinakis; Dimitrios Maragiannis; Leonidas Raftopoulos; Petros Arsenos; Konstantinos Gatzoulis; Christodoulos Stefanadis
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-01       Impact factor: 1.468

4.  A pilot study of QT interval analysis in overweight and obese youth.

Authors:  Shirleatha Lee; Patricia Ann Cowan; Pedro Velasquez-Mieyer
Journal:  Appl Nurs Res       Date:  2011-01-20       Impact factor: 2.257

5.  Childhood and Adolescent Migraine Prevention (CHAMP) study: a double-blinded, placebo-controlled, comparative effectiveness study of amitriptyline, topiramate, and placebo in the prevention of childhood and adolescent migraine.

Authors:  Andrew D Hershey; Scott W Powers; Christopher S Coffey; Dixie D Eklund; Leigh Ann Chamberlin; Leslie L Korbee
Journal:  Headache       Date:  2013-04-17       Impact factor: 5.887

6.  Effects of sex on the pharmacokinetic and pharmacodynamic properties of quinidine.

Authors:  Hala El-Eraky; Simon H L Thomas
Journal:  Br J Clin Pharmacol       Date:  2003-08       Impact factor: 4.335

Review 7.  Sex differences in cardiac autonomic regulation and in repolarisation electrocardiography.

Authors:  Peter Smetana; Marek Malik
Journal:  Pflugers Arch       Date:  2013-02-13       Impact factor: 3.657

8.  Rhythm and conduction analysis of patients with acute rheumatic fever.

Authors:  Sevket Balli; Mehmet Burhan Oflaz; Ayse Esin Kibar; Ibrahim Ece
Journal:  Pediatr Cardiol       Date:  2012-08-07       Impact factor: 1.655

9.  Dispersion of QT and QTc interval in healthy children, and effects of sinus arrhythmia on QT dispersion.

Authors:  H E Tutar; B Ocal; A Imamoglu; S Atalay
Journal:  Heart       Date:  1998-07       Impact factor: 5.994

10.  QTc interval prolongation in children with Turner syndrome: the results of exercise testing and 24-h ECG.

Authors:  Robert Dalla Pozza; Susanne Bechtold; Simon Urschel; Heinrich Netz; Hans-Peter Schwarz
Journal:  Eur J Pediatr       Date:  2008-04-05       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.